Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Beyond increased risk: Obesity complicates cancer diagnosis, treatment
-
- Diabetes delivers ‘health shock’ to education, employment for young adults
- FDA approves exenatide extended-release for injectable suspension in type 2 diabetes
- FDA risk communication system yielded inconsistent results
- Molecular testing may mitigate mystery of indeterminate thyroid nodules
- New bisphosphonate users who adhere to dosing recommendations at lower risk for fracture
- Overall US obesity prevalence steady during 12-year period
- Stricter standards needed for guidelines on oral diabetes treatments
- An important contribution: Role of ADT and endocrinologists in treating unacceptable sexual behavior Stanley Korenman, MD
-
- AMA calls on Congress to ‘stop stalling,’ stabilize Medicare
- CT scan reveals adrenal mass Stephanie L. Lee, MD, PhD, ECNU; Grace Huang, MD
- Adiponectin associated with dementia, Alzheimer’s disease risk in women
- High serum TSH linked to systolic, diastolic BP in children, adolescents
- Novel classes of drugs identified with antiproliferative effect in thyroid cancer
- Real-time continuous glucose monitoring improved glycemic control in type 2 diabetes
- Several risk factors associated with vitamin D deficiency in children
- Statin use may raise risk for diabetes in postmenopausal women
-
- Study: 15-year interval appropriate for osteoporosis screening among older, postmenopausal women with normal BMD
- Surgical menopause not associated with significant increase in fracture risk
- Understanding suitability of health care services difficult, may lead to overuse in US
- War on obesity takes a hit Ryan Novosad, PharmD; Sara Brouse, PharmD, FCCP, BCPS, AQ-Cardiology